James Paul Lang - Net Worth and Insider Trading

James Paul Lang Net Worth

The estimated net worth of James Paul Lang is at least $416,755 dollars as of 2024-05-14. James Paul Lang is the Director of OptimizeRx Corp and owns about 38,660 shares of OptimizeRx Corp (OPRX) stock worth over $416,755. Details can be seen in James Paul Lang's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James Paul Lang has not made any transactions after 2022-08-19 and currently still holds the listed stock(s).

Transaction Summary of James Paul Lang

To

James Paul Lang Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Paul Lang owns 2 companies in total, including OptimizeRx Corp (OPRX) , and BioVie Inc (BIVI) .

Click here to see the complete history of James Paul Lang’s form 4 insider trades.

Insider Ownership Summary of James Paul Lang

Ticker Comapny Transaction Date Type of Owner
OPRX OptimizeRx Corp 2022-08-19 director
BIVI BioVie Inc 2022-04-05 director

James Paul Lang Latest Holdings Summary

James Paul Lang currently owns a total of 1 stock. James Paul Lang owns 38,660 shares of OptimizeRx Corp (OPRX) as of August 19, 2022, with a value of $416,755.

Latest Holdings of James Paul Lang

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OPRX OptimizeRx Corp 2022-08-19 38,660 10.78 416,755

Holding Weightings of James Paul Lang


James Paul Lang Form 4 Trading Tracker

According to the SEC Form 4 filings, James Paul Lang has made a total of 1 transactions in OptimizeRx Corp (OPRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in OptimizeRx Corp is the acquisition of 6,000 shares on August 19, 2022, which cost James Paul Lang around $98,700.

Insider Trading History of James Paul Lang

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

James Paul Lang Trading Performance

GuruFocus tracks the stock performance after each of James Paul Lang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James Paul Lang is 29.31%. GuruFocus also compares James Paul Lang's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Paul Lang within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how James Paul Lang's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of James Paul Lang

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.25
Relative Return to S&P 500(%) 0.52

James Paul Lang Ownership Network

Ownership Network List of James Paul Lang

No Data

Ownership Network Relation of James Paul Lang


James Paul Lang Owned Company Details

What does OptimizeRx Corp do?

Who are the key executives at OptimizeRx Corp?

James Paul Lang is the director of OptimizeRx Corp. Other key executives at OptimizeRx Corp include General Counsel and CCO Marion Odence-ford , Chief Commercial Officer Theresa Greco , and Chief Product Officer Doug Besch .

OptimizeRx Corp (OPRX) Insider Trades Summary

Over the past 18 months, James Paul Lang made no insider transaction in OptimizeRx Corp (OPRX). Other recent insider transactions involving OptimizeRx Corp (OPRX) include a net sale of 4,000 shares made by Marion Odence-ford ,

In summary, during the past 3 months, insiders sold 0 shares of OptimizeRx Corp (OPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,000 shares of OptimizeRx Corp (OPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,000 shares.

OptimizeRx Corp (OPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

OptimizeRx Corp Insider Transactions

No Available Data

James Paul Lang Mailing Address

Above is the net worth, insider trading, and ownership report for James Paul Lang. You might contact James Paul Lang via mailing address: C/o Biovie, 2120 Colorado Avenue, Suite 230, Santa Monica Ca 90404.

Discussions on James Paul Lang

No discussions yet.